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Abstract
Aims: Human atrial electrophysiology exhibits high inter-subject variability in both sinus rhythm (SR) and chronic atrial
fibrillation (cAF) patients. Variability is however rarely investigated in experimental and theoretical electrophysiological
studies, thus hampering the understanding of its underlying causes but also its implications in explaining differences in the
response to disease and treatment. In our study, we aim at investigating the ability of populations of human atrial cell
models to capture the inter-subject variability in action potential (AP) recorded in 363 patients both under SR and cAF
conditions.
Methods and Results: Human AP recordings in atrial trabeculae (n = 469) from SR and cAF patients were used to calibrate
populations of computational SR and cAF atrial AP models. Three populations of over 2000 sampled models were
generated, based on three different human atrial AP models. Experimental calibration selected populations of AP models
yielding AP with morphology and duration in range with experimental recordings. Populations using the three original
models can mimic variability in experimental AP in both SR and cAF, with median conductance values in SR for most ionic
currents deviating less than 30% from their original peak values. All cAF populations show similar variations in GK1, GKur and
Gto, consistent with AF-related remodeling as reported in experiments. In all SR and cAF model populations, inter-subject
variability in IK1 and INaK underlies variability in APD90, variability in IKur, ICaL and INaK modulates variability in APD50 and
combined variability in Ito and IKur determines variability in APD20. The large variability in human atrial AP triangulation is
mostly determined by IK1 and either INaK or INaCa depending on the model.
Conclusion: Experimentally-calibrated human atrial AP models populations mimic AP variability in SR and cAF patient
recordings, and identify potential ionic determinants of inter-subject variability in human atrial AP duration and morphology
in SR versus cAF.
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Introduction
Atrial arrhythmias constitute a huge burden to health-care
systems in the developed countries, both because of their high rate
of incidence and also because they usually lead to other deadly
cardiovascular diseases such as stroke [1]. A large body of research
has aimed at characterizing human atrial membrane kinetics and
their implication in cellular and tissue electrophysiology, in an
attempt to improve our understanding of the initiation and
maintenance of atrial arrhythmias [2]. An important challenge in
understanding human atrial electrophysiology is the large inter-
subject variability present in electrophysiological recordings
obtained from human samples. Characterizing and understanding
inter-subject variability in atrial cellular electrophysiology is
important to determine not only the physiological range of action
potential (AP) properties, but also differences under disease
conditions and in the response to treatment between patients.
The causes of electrophysiological variability are largely unknown.
However, recent studies highlight its temporally-dynamic nature
and a variety of causes, pointing towards genetic differences
(including sex [3]) but also factors such as age, circadian rhythms
[4] and long term drug effects [5].
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In spite of its potential importance, variability is often ignored in
both experimental and theoretical studies of atrial electrophysiol-
ogy properties, probably due to its complexity.
Experimental studies often focus on average values obtained in
a limited number of recordings. This is reflected in theoretical
studies, and mathematical models of human atrial electrophysiol-
ogy reported in the literature are all based on a single set of
parameters. The human atrial models therefore yield a single AP,
which exhibits significant differences in shape and duration for
different models under similar simulated conditions [6]. The
differences in outcomes obtained using different human atrial
models may in fact reflect the large degree of variability in the data
that are used in their construction.
Recently, inter-subject variability in electrophysiological
properties has been investigated in a number of studies, which
have mostly focused on ventricular rather than atrial electro-
physiology [7–10]. Previous studies include, amongst others,
investigation of the ionic basis of variability in human
ventricular APs [11], in canine ventricular AP for drug safety
assessment [12], in rabbit Purkinje cellular electrophysiology for
investigation of variability in the response to drug action [13]
and in rabbit ventricular electrophysiology at different pacing
rates [14]. Furthermore, inter-subject variability has also been
previously investigated in studies with other cell types such as
neuronal electrical activity in crabs for either the study of
variability in channel expressions [15], or the correlation
between channel expressions [16], and variability in human
ventricular APs in heart failure [11].
As a way to incorporate experimentally-reported variability in
mathematical models of biological systems, a population of models
approach has been recently proposed for cellular electrophysiology
[8,11,13,14,17,18]. The population of models approach aims to
provide a new framework to overcome an important limitation of
current models imposed by the implicit assumption that all cells of
a certain type have quantitatively identical ionic properties.
Simulation studies using populations of models allow exploring
potential causes and implications of the cell level variability
exhibited in experimental recordings, and thus aim at facilitating
the generation of new hypothesis on likely mechanisms of
variability that are otherwise very opaque using experimental
techniques alone.
In this study, we investigate the ability of populations of human
atrial AP models based on three recently published models to
capture the inter-subject variability in human atrial AP, as
exhibited in recordings from over 350 atrial trabeculae from sinus
rhythm (SR) and chronic AF (cAF) patients. The human atria
models within each population (based on one of the three models)
share the same equations but include different combinations of
sampled ionic current conductance values, as previously de-
scribed [8,9,11,13,19]. The experimentally-calibrated human
atrial AP model populations are then used to quantify the
contribution of specific ionic currents to determining inter-subject
variability in cellular human atrial AP duration (APD) and
morphology in the populations, and to determine potential
differences between the populations based on SR and cAF
patients’ recordings. Three different baseline AP models are used
in our study to construct the populations in both SR and cAF.
This is done in order to consider differences in the structure of
the models equations as well as in parameters in our investiga-
tions, and also to evaluate the model independence of the
identified mechanisms of variability.
Methods
Experimental Dataset
The experimental datasets were obtained in studies with human
samples conforming to the Declaration of Helsinki. The study was
approved by the Ethics Committee of Dresden University of
Technology (No. EK790799). Each patient gave written, informed
consent. Right atrial appendages were obtained from 363 patients
with SR (214 patients) and with cAF (149 patients) undergoing
cardiac surgery for coronary artery bypass grafting or mitral/
aortic valve replacement. SR patients may include atrial tissue
from AF patients that have had paroxysmal and recent onset AF.
Antiarrhythmic drugs were discontinued before the study.
APs were recorded with standard intracellular microelectrodes
in atrial trabeculae (469 recordings from 363 patients: SR,
n = 254, from 214 patients; cAF, n = 215, from 149 patients)
[20,21]. Bath solution contained (in mM): NaCl 127, KCl 4.5,
MgCl2 1.5, CaCl2 1.8, glucose 10, NaHCO3 22, NaH2PO4 0.42,
equilibrated with O2-CO2 [95:5] at 36.560.58uC, pH 7.4.
Preparations were regularly stimulated at 1 Hz for at least 1 h
before data acquisition [20,21]. Human myocytes were isolated
enzymatically from atrial appendages as previously described [22].
The following parameters were quantified to characterize inter-
subject variability in human atrial AP: APD at 20, 50, and 90%
repolarization (APD20, APD50, APD90, respectively), AP ampli-
tude (APA), resting membrane potential (RMP), plateau potential
defined as the potential measured at 20% of the APD90 time (V20),
and maximum upstroke velocity (dV/dtmax). Minimum, maximum
and mean6standard deviation values for these biomarkers are
presented in Table 1.
Human Atrial Electrophysiology Cell Models
Three recent human atrial AP models were used as a base to
construct the computational AP model populations, the Maleckar
et al. [23], the Courtemanche et al. [24], and the Grandi et al. [25]
models. For simplicity, these models will be referred to in the text
by their first authors’ names.
All three models provide biophysically-detailed descriptions of
human atrial cellular electrophysiology including main transmem-
brane ionic currents, including the fast sodium current INa, the L-
type calcium current ICaL, the transient outward potassium current
Ito, the ultra-rapid potassium current IKur, the inward rectifier
potassium current IK1, the rapid and slow components of the
delayed rectifier potassium current (IKr and IKs) and those
associated with the sodium/potassium pump (INaK) and the
sodium/calcium exchanger (INaCa). The models also include
representation of the intracellular calcium handling and ionic
homeostasis regulating sodium, potassium and calcium intracellu-
lar concentrations, which also determine the time course of the
human atrial AP. Human atrial cell models have been reviewed in
detail in previous publications [6,26–28] and here we provide a
brief description on their main characteristics.
The Maleckar model is a modified version of the original
human atrial model by Nygren et al. [29], which includes a
reformulation of IKur and Ito to better reproduce rate dependent
properties. The calcium subsystem is based on the rabbit atrial
model by Lindblad et al. [30]. The Maleckar model yields a
simulated AP with a triangular shape, and a calcium transient with
large peak and rapid decay. The Courtemanche model is one of
the first human atrial cell models, published in 1998, the same year
the Nygren model was also published. Both models include
representation of the 12 main transmembrane ionic currents,
largely based on the same human atrial model but with significant
model differences. In the Courtemanche model for example, the
Variability in Human Atrial Electrophysiology
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calcium dynamics are based on the Luo-Rudy dynamic AP model
[31]. Thus, the simulated AP using the Courtemanche model is
characterized by a longer plateau phase and less triangular shape
compared to the Nygren and Maleckar models, and also a longer-
lasting calcium transient with a rapid upstroke but slow decay.
Finally, the Grandi model was developed largely based on their
previous human ventricular model [32], and therefore the
formulation of transmembrane currents and calcium dynamics
differs significantly from the Maleckar and Courtemanche models.
In addition to the main transmembrane currents, the Grandi atrial
model also includes the formulation of two chloride and a
potassium plateau current. The calcium subsystem model is based
on the one in the rabbit ventricular model by Shannon et al. [33].
The AP morphology is triangular with a longer APD than the one
obtained with the other models, and the calcium transient displays
a slow rise but low amplitude and slow decay.
Populations of Models of Human Atrial Electrophysiology
To capture inter-subject variability, three populations of
sampled models of human atrial electrophysiology for both SR
and cAF were generated, each one based on one of the original AP
models (i.e. Maleckar, Courtemanche and Grandi models). All
models in each population shared the same equations but the most
important ionic current conductances in determining the human
atrial AP were varied with respect to their original values [34].
According to our previous sensitivity analysis study [34], the most
relevant parameters were the conductances of IK1, ICaL, Ito, IKur,
and maximal sodium/potassium pump (INaK) and sodium/
calcium exchanger currents (INaCa) [34]. Most other ionic current
conductances and gating variable kinetics exhibit small or
negligible effects on the investigated AP biomarkers.
Our first step is to estimate the median values and range of
variation for the six key ionic conductances required to obtain
simulated APs to be within experimental range for each of the
models. To do so and to minimize computational expense, we first
constructed coarse model populations with 2275 different ionic
conductance combinations sampled over a 6100% variation
range around their values in the original models, using the
methodology described in [35]. The method works by varying
different parameters at different frequencies, encoding the identity
of parameters in the frequency of their variation. Briefly, the
sampling methodology consists of first generating sinusoidal
functions with particular frequencies with NS samples for each
ionic conductance (i.e. a search curve). The frequencies assigned to
the parameters must meet several criteria to avoid aliasing and
interference effects; see [35] for a detailed discussion of how
frequencies are chosen. Then search curves were randomly
resampled NR times to avoid repetition of values due to the
periodicity properties of sinusoidal functions. The total number of
models for each population, 2275, was obtained by multiplying NS
( = 65), NR ( = 5) and the number of ionic conductances ( = 6) plus
an additional ‘‘dummy’’ (free) parameter ( = 6+1). The free
parameter is used as a security step to guarantee the statistical
significance of the other parameters (i.e., the ionic conductances)
to round-off artifacts in the global method as described previously
[35]. We ensured that the 2275 combinations were consistent with
the sampling methodology without losing sampling resolution [35].
Since we used three different original AP models, the total number
of unrestricted combinations of parameters was 6825.
The Maleckar, Courtemanche and Grandi default models were
initially preconditioned by pacing at 1 Hz (using a 2 ms stimulus
duration, twice diastolic threshold amplitude) until the steady-state
was reached (changes in state variables between consecutive
stimuli measured at the end of each cardiac cycle smaller than
1%). All AP models within the populations were paced at 1 Hz,
and APs were analyzed following a train of 90 periodic stimuli to
quantify APD20, APD50, APD90, APA, RMP, V20 and dV/dtmax
for each model in each of the populations. AP models were
selected as in physiological range if all AP properties were in the
experimental ranges described in Table 1 for SR and cAF,
respectively. Models with AP properties out of the experimental
ranges described in Table 1 were discarded from the populations.
Additionally, models presenting abnormalities such as delayed
afterdepolarizations (DADs) were also removed for subsequent
analysis. Figure 1 shows median physiological values for each of
the six ionic conductances from these initial populations calibrated
with the human atria recordings for SR and cAF patients. Note
that most median values deviate from the original model value
(represented as 0% in Figure 1), indicating that the original models
are not representative of median behavior in our experimental
recordings and that the calibration step is required. The deviation
of the median value from the original one is often moderate for all
ionic currents and all models, and within a 630% range in SR,
with the exception of the sodium/calcium exchanger in the
Maleckar model which requires a significant up-regulation in SR
(+65%) for models to be within physiological range, as shown in
Table 2. The ranges obtained for each of the conductances vary
significantly between ionic currents, indicating differences in the
sensitivity of the AP to variation in each of the currents. The ionic
ranges in SR and cAF often overlap, reflecting that there is also
overlap in the AP biomarkers distributions. Importantly, a
comparison between SR and cAF shows an overall increase in
Table 1. Human atrial AP biomarkers’ ranges in SR and cAF patients.
SR cAF
Minimum Value Maximum Value Mean6SD Minimum Value Maximum Value Mean6SD
APD90 (ms) 190 440 318642 140 330 216635***
APD50 (ms) 6 200 139644 30 180 102628***
APD20 (ms) 1 60 768 1 75 30618***
APA (mV) 75 120 9567 80 130 10268***
RMP (mV) 285 265 27464 285 265 27764***
V20 (mV) 235 10 21666 230 20 24611***
dV/dtmax (V/s) 40 420 220668 40 420 232670*
(Statistical significance between SR and cAF: *p,0.05; **p,0.01; ***p,0.001).
doi:10.1371/journal.pone.0105897.t001
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GK1 and a decrease in Gto and GKur in cAF using the three models
(except for no significant changes in GKur with the Courtemanche
model, see Table 2). The results are consistent with the
remodeling in those currents reported experimentally [36–38],
and also highlights the importance of those conductances in the
differences in AP between SR and cAF recordings. However,
GCaL increases in cAF with respect to SR with the three models, in
contrast with previous studies showing a decrease in GCaL [37].
Table 2. Percentage of variation of the median values subject to 95% confidence interval for GK1, GNaK, GCaL, Gto, GKur and GNaCa for
SR and cAF with respect the default values in the Maleckar, Courtemanche and Grandi models, respectively.
Maleckar Courtemanche Grandi
SR cAF SR cAF SR cAF
GK1 21263% +3865% +164% +2664% +1867% +2662%
GNaK +2767% +5165% 2265% 21065% 22763% 24561%
GCaL +20612% +3768% +2464% +1264% +1267% +1762%
Gto +16615% 21069% 22365% 23565% 2266% 21062%
GKur +9617% 22968% 2465% 2165% 21267% 22261%
GNaCa +6568% +3367% +965% +165% +366% +962%
doi:10.1371/journal.pone.0105897.t002
Figure 1. Ranges of variability of ionic conductances in the human atrial AP model populations. Median values and ranges of variability
of ionic conductances GK1, GNaK, GCaL, Gto, GKur and GNaCa in the experimentally-calibrated populations of human atrial AP models, sampled within a
6100% range of their original values in the Maleckar (A), Courtemanche (B) and Grandi (C) human atria AP models in SR (blue) and cAF (red). Each
boxplot represents the range covered by the ionic conductances: the edges of the box are the 1st and 3rd quartiles, the whiskers extend to the most
extreme datapoints, the estimated median physiological value is the central horizontal line and the notch around the median is the 5% significance
level. (Mann-Whitney U test: *p,0.05; **p,0.01; ***p,0.001).
doi:10.1371/journal.pone.0105897.g001
Variability in Human Atrial Electrophysiology
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The differences are likely to reflect the fact that ICaL is both voltage
and calcium dependent. Therefore, the effect of variability in GCaL
on the AP would also be dependent on calcium dynamics, which
are different in the three baseline models.
Once the median value for each ionic conductance was
estimated as described above, we refined the populations of
sampled models by constructing newly generated populations of
2275 AP models with ionic currents sampled in the 630% range
around the estimated median physiological values. Both the
sampling resolution and number of accepted models in the six final
AP model populations was thus maximized, since most of the
models accepted in the 6100% range population were within the
630% range with respect to the median. This is also in good
agreement with the 630% range of variability considered in
previous studies [7,19,39]. The refined human atrial model
populations were then calibrated again to ensure that all models
in the populations remained in range with their corresponding
experimental ranges (SR or cAF) as described in Table 1.
The percentage of accepted models was 65.5% with the
Maleckar model in SR and over 93% in the rest of cases, as
shown in Table 3. The main cause of differences in the number of
models excluded from the population is that the Maleckar model is
more prone to generate DADs at slow pacing than the
Courtemanche and Grandi models under certain electrophysio-
logical conditions, such as reduced INaK current [26].
Statistical Analysis
Regression methods were used for the quantification of the
main determinants of inter-subject electrophysiological variability
[8,13,19]. The dependence of APD20, APD50 and APD90 on
pairwise combinations of multiple ionic properties was analyzed
using second-order multi-parametric regression on the accepted
model populations. This was studied by calculating the coefficient
of determination (R2) of the computed regressions: the higher R2
the stronger the dependence of APD on the considered
parameters. A third parameter was included in the analysis for
those cases where R2,0.7. Mechanisms of AP triangulation,
calculated as the difference between APD90 and APD50, were also
analyzed by regression techniques. The Mann-Whitney U test was
used to determine statistical significance in differences on ionic
conductance distributions between populations. Box plots, includ-
ing median values and confidence intervals, as well as empirical
cumulative distribution curves were constructed using the Matlab
statistics toolbox (functions ‘‘boxplot’’ and ‘‘ecdf’’, respectively).
Results
Ionic Determinants of Inter-subject APD Variability
Figure 2 shows the wide range of AP morphologies for human
atrial cell models in SR and cAF (left and right, respectively)
obtained in simulations using the initial unrestricted population
(with ionic currents sampled over a 6100% range of their original
values, panel A), and the most restricted range of variability
obtained with the experimentally-calibrated populations (panel B).
Histograms show distributions of APD values obtained in the
population in the simulations (panel C) and in the experimental
recordings (panel D) across the experimental range. Results in
Figure 2 are shown for the Courtemanche model and slightly
different coverage of the experimental range is provided for the
Maleckar and Grandi models (Figures S1 and S2 in Supplemental
Material). In order to further illustrate the comparison between
simulated and experimental APD distributions, Figure 3 shows the
empirical cumulative distribution curves of the experimental and
model population values of APD90, APD50 and APD20. The curves
allow a clear comparison of the probability distributions and the
degree of variability between experimental and simulated data. As
illustrated in Figures 2, 3, S1 and S2, experimentally-calibrated
populations of human atrial models are able to capture in most
cases the wide inter-subject variability in AP duration and
morphology exhibited in the experimental recordings, quantified
using the properties and values shown in Table 1. The results also
display differences between the populations generated with the 3
baseline models. In particular, the population based on the
Courtemanche model covers similar ranges and with similar
probability distributions to experimental APD90, APD50 and
APD20 distributions in SR, but the agreement of APD ranges
and probability distributions with experiments in cAF is not as
good (Figures 2 and 3). In contrast, the population based on the
Maleckar model provides the best agreement in the ranges and
degrees of variability of APD90 and APD50 in cAF, but the
agreement for APD values is worse in SR (Figure S1 and 3). The
population with the Grandi model covers shorter ranges of APDs
than experimental recordings, but the range and probability
distribution of APD20 in SR is larger than those obtained with
Courtemanche and Maleckar populations (Figure S2 and 3).
Overall for all populations, the experimental range for APD20 in
cAF is wider than the range obtained for simulated values for all
three populations. This could be due to a variety of factors
including the need for further refinement of the sampling
methodology to allow for more parameters or wider parameter
ranges to be considered, but it could also be due to the high
sensitivity of APD20 to experimental protocols and conditions,
which would require further investigations. Figure 4 illustrates the
variability in the time-course of the ionic currents in the calibrated
population with the Maleckar model and those underlying the
maximum and minimum APD values measured at the different
stages of repolarization in the human atrial models. Simulations
show that most currents exhibit variability mainly in their peak
value, as shown for Ito, IKur and INaCa. However, IK1, INaK and
ICaL exhibit inter-subject variability also in their sustained current
densities. Particularly, the rate of decay of ICaL was found to be
markedly slower for cellular models with longer APD values, and
more so in the cAF than in SR populations. Similar results were
obtained with the Courtemanche, with slightly larger variability in
Table 3. Number and percentages of accepted sampled models in the experimentally-calibrated Maleckar, Courtemanche and
Grandi populations in SR and cAF out of a total of 2275 sampled models.
SR cAF
Maleckar 1489 (65.5%) 2177 (95.7%)
Courtemanche 2275 (100%) 2271 (99.8%)
Grandi 2125 (93.4%) 2275 (100%)
doi:10.1371/journal.pone.0105897.t003
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IKur and INaCa, and Grandi models, as shown in Figures S3 and
S4, respectively. Figures 5 and 6 further illustrate the ionic
mechanisms of inter-subject variability in the simulated human
atrial AP models shown in Figure 4. They provide quantitative
results on variability from the regression analysis described in the
Methods for human atrial APD90, APD50 and APD20 with respect
to their most important pairs of ionic modulators. Results are
shown for the populations of sampled models constructed for the
Maleckar (A–C), Courtemanche (D–F), and Grandi (G–I) in SR
(Figure 5) and cAF conditions (Figure 6).
In spite of differences in ionic ranges between SR and cAF,
simulations show similar ionic mechanisms of variability in SR and
cAF (irrespective of the original underlying model). Variability in
IK1 and importantly also in INaK entails variability in APD90 in
both SR (Figures 5A, 5D and 5G) and cAF (Figures 6A, 6D and
6G). Results with the Courtemanche model population indicate an
additional role of variability in ICaL on variability in APD90
(Figure 5D; Figure 6D).
Regarding APD50 variability, our population-based analysis
identifies variability in ICaL and IKur as key at the early stage of
repolarization, followed by a secondary role of variability in IK1
and INaK, particularly with the Grandi model population, in both
SR and cAF (Figures 5B, 5E and 5H; Figures 6B, 6E and 6H).
Finally, variability in APD20 strongly depends on variability in
Ito and IKur in both the SR (Figures 5C and 5F) and cAF
(Figures 6C, 6F and 6I) populations, as shown by comparing the
results from all six model populations. These effects are concealed
by changes in IK1 and INaK in the Grandi model population in
both SR and cAF conditions (Figures 5I and 6I). Variability in
ICaL is relevant as well for the modulation of APD20 variability in
the Courtemanche model population (Figure 4F).
Figure 7 summarizes the elucidated ionic mechanisms modu-
lating APD in each repolarization stage with the model
populations in SR (panel A) and cAF (panel B). In both SR and
cAF, variability in IK1 and INaK modulate variability in APD90,
ICaL and IKur in APD50, and Ito and IKur in APD20. The main
Figure 2. Experimentally-calibrated human AP model populations for SR and cAF based on the Courtemanche model. Initial
unrestricted 6100% sampled population (A), experimentally calibrated 630% sampled populations (B) and histograms corresponding to APD90,
APD50 and APD20 distributions in both the calibrated model populations (C) and the experimental measurements (D). Histogram bar widths are
10 ms for both APD90 and APD50, and 4 ms for APD20.
doi:10.1371/journal.pone.0105897.g002
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differences between SR and cAF in terms of ionic mechanisms are
found in the populations based on the Grandi model, which depict
decreased relevance of variability in IK1 and INaK in modulating
the early stages of atrial cell repolarization in the cAF Grandi
models, and a reduced role of variability in ICaL in regulating APD
at all stages of repolarization in cAF.
Ionic Determinants of Variability in AP Morphology
Figure 8 shows the most significant differences in AP morphol-
ogy, quantified through AP triangulation, obtained within the
populations based on the Maleckar (Figure 8A), Courtemanche
(Figure 8B) and Grandi (Figure 8C) models. Our simulation
results show that our populations of models are able to capture
a large inter-subject variability in AP morphology, as measured in
our recordings and also reported in previous studies [40–42]. The
regression analysis reveals variability in IK1 and INaK as the main
underlying mechanisms of AP triangulation in the Maleckar and
Grandi model populations (R2.0.96), whereas the combination of
changes in IK1 and INaCa leads to the highest regression values with
the Courtemanche model populations (R2 = 0.86). Figure 8 (panels
D and F) further identifies the combination of IK1 with either INaK
or INaCa (depending on the model) as the main properties leading
to the different AP morphologies. The most triangular APs were
generated for combinations of decreased IK1 and increased INaK
(Maleckar and Grandi) or increased reverse-mode of the INaCa
(Courtemanche) current amplitudes.
Inter-subject Variability in Rate Dependence
Inter-subject variability in APD rate dependent properties of
human atrial cardiomyocytes was also investigated by comparing
the response of our populations of sampled human atrial models at
1 Hz, 2.5 Hz and 3 Hz pacing rates. Overall, our results are
qualitatively similar for the three pacing rates and the role played
by the ionic currents at the different stages of repolarization is
similar at the three pacing rates. Only an increased relevance of
variability in ICaL and IKur on the last repolarization stage can be
found at fast pacing. Pacing rates faster than 3 Hz were not
studied since they result in the stimulus application during the
Figure 3. Empirical cumulative distribution curves for APD90, APD50 and APD20. Curves for experimental data (black) and the populations
of models based on the Maleckar (blue), Courtemanche (red) and Grandi (magenta) models in both SR (top panels) and cAF (bottom panels).
doi:10.1371/journal.pone.0105897.g003
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repolarization phase of the cellular models with longer APD90
within the populations. This would lead to stimulus-induced APD
prolongation, and would create artefacts in the values of APD
measured.
A specific feature of the Grandi population is that the models
are particularly prone to exhibit AP alternans at fast pacing rates,
with low amplitude and slow upstrokes in a significant percentage
of the models within both SR and cAF populations. This is in
agreement with previous experimental studies [43–46]. Figure 9
(panel A) shows clear alternating behavior in a large number of
models in the Grandi model population in SR for 2.5 Hz pacing.
The alternating behavior occurs in models with both low
amplitude of IK1 and increased activity of INaK (Figure 9B). This
is in good agreement with the important role played by both ionic
currents in modulating APD at the different stages of repolariza-
tion (Figure 7). Furthermore, Figure 9 (panel B) shows the effects
of the rest of ionic currents in generating alternans are less
statistically significant and Ito is the only additional ionic current
with a notable effect in its variability.
Discussion
In this study, populations of models based on three human atrial
AP models are able to mimic a wide range of inter-subject
variability in human atrial AP properties as exhibited in a
comprehensive set of electrophysiological recordings, obtained
from over 350 SR and cAF patients [6]. In our analysis, we
considered recordings obtained in a large number of patients with
different etiologies, and therefore exhibiting a remarkable range of
APD90 variability of up to 250 ms in SR and 190 ms in cAF. Our
results show that a large range of the experimental AP variability
can be recovered in the simulations with the model populations.
Relatively modest 630% variations in ionic conductances are
often sufficient using the three models, and around median values
that also deviate less than 30% from their original values. We
specifically consider three widely used different human atrial AP
models to assess potential differences and similarities in the results
obtained with them.
The actual ‘‘true’’ range of ionic variability in the specific
experimental samples used to record the APs is of course
unknown. The AP traces do not contain enough information to
Figure 4. Transmembrane potential and ionic current traces in SR and cAF for the Maleckar model-based populations. Traces for
models displaying maximum APD90 (red dash-dotted lines), minimum APD90 (black dash-dotted lines), maximum APD50 (red thin solid lines),
minimum APD50 (black thin solid lines), maximum APD20 (red dashed lines) and minimum APD20 (black dashed lines). Insets provide detailed views of
peak Ito current.
doi:10.1371/journal.pone.0105897.g004
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uniquely determine all ionic properties. Furthermore, ionic
currents cannot be measured in tissue, and voltage clamp
measurements have the inherent limitations of using isolated
single cells, whose channels are known to be affected by the
isolation procedure [47]. In fact, even if we were able to measure
the ionic conductances at a specific moment in time, they are
subject to continuous variations caused by extrinsic factors, such as
circadian rhythms in plasma level concentrations [4] or long term
drug effects [5]. Therefore, through our computational popula-
tions of models approach, we aim at and are able to identify and
suggest what may be likely ranges and important players in
explaining the variability in the human AP recordings [48–50].
This is no different to any other theoretical or experimental
modelling study, which should aim at probing and refining our
understanding of biological systems [51,52]. The credibility of our
findings is supported by similarities in the mechanisms identified
using the three different models, and also by their agreement with
previous experimental and theoretical studies. Further studies will
aim at challenging our predictions and methodologies under
different clinical and experimental conditions.
Through the combination of our population approach with a
large experimental recordings dataset, we therefore expand our
understanding of potential underlying causes of human atrial AP
variability. An important methodological novelty is that it allows
identifying how synergistic combinations of various ionic current
densities could determine inter-subject variability in the human
atrial AP, which goes an important step beyond previous
sensitivity analysis methods [7,39,53]. Therefore, we are able to
suggest how complex non-linear combinations of simultaneous
variability in multiple ionic conductances, as may be present in
different individuals, lead to differences in atrial cellular repolar-
ization in SR versus cAF models. Our results may provide the
basis for a deeper understanding on the penetration of different
pharmacological therapies at the population level, which is critical
in the interpretation of outcomes for anti-arrhythmic drug
development and the lack of pharmacological response in some
individuals. This could be the focus of further studies, as was done
in [9] for dofetilide in rabbit Purkinje studies.
The median electrophysiological values and ranges extracted
from the initial populations differed between SR and cAF, as
shown in Figure 1. Calibration of the populations with cAF
recordings leads to notably higher median values of GK1 in cAF,
reduction in Gto and reduction in GKur (the latter to a lesser extent
in the Courtemanche model). The predictions in repolarizing
currents are in good agreement with the ionic remodeling
observed in cAF atrial cardiomyocytes in previous experimental
studies [36–38].
The analysis of the six model populations yields in most cases
consistent results in terms of the ionic properties identified as
determining variability in the different phases of the AP
repolarization. Variability in IK1 and INaK is identified as key in
explaining inter-subject variability in APD90 and AP morphology.
Figure 5. Ionic conductances determining inter-subject variability in human atrial repolarization in the SR AP model populations at
1 Hz. Regression surfaces for APD90, APD50 and APD20 are presented with respect to the two most significant ionic factors determining their
variability, using populations based on the Maleckar (A–C), Courtemanche (D–F), and Grandi (G–I) models. Regression surfaces are color coded
according to APD magnitudes, whereas each big dot denotes the value for one model in the calibrated populations.
doi:10.1371/journal.pone.0105897.g005
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Figure 6. Ionic conductances determining inter-subject variability in human atrial repolarization in the cAF AP model populations
at 1 Hz. Figure annotation as in Figure 5.
doi:10.1371/journal.pone.0105897.g006
Figure 7. Ionic modulators of APD90, APD50 and APD20 in SR and cAF. Ionic conductances identified as having a stronger influence on
human atrial cells APD90 (blue), APD50 (green) and APD20 (magenta), in SR (A) and cAF (B) with the Maleckar, Courtemanche and Grandi model
populations.
doi:10.1371/journal.pone.0105897.g007
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Figure 8. Inter-subject variability in human atrial AP triangulation. The most and least triangular APs in each population are shown (solid
and dotted lines, respectively), obtained with the Maleckar (A), Courtemanche (B) and Grandi (C) models in SR. Corresponding time-course of ionic
mechanisms of AP triangulation are shown: IK1 and INaK (D and F), IK1 and INaCa (E).
doi:10.1371/journal.pone.0105897.g008
Figure 9. AP traces and variability of ionic conductances with the population based on the Grandi model in SR at 2.5 Hz. (A)
Accepted models as for 1 Hz pacing are shown in blue, whereas models exhibiting pronounced AP alternans (|APD90,odd – APD90,even| .30 ms) and
strong AP alternans (|APD90,odd – APD90,even| .100 ms) are shown in magenta and black, respectively. (B) Variability of ionic conductances GK1, GNaK,
GCaL, Gto, GKur and GNaCa for the models in panel A. Each boxplot represents the range covered by the ionic conductances: the edges of the box are
the 1st and 3rd quartiles, the whiskers extend to the most extreme datapoints, the estimated median physiological value is the central horizontal line
and the notch around the median is the 5% significance level. (Mann-Whitney U test vs. accepted range: *p,0.05; **p,0.01; ***p,0.001).
doi:10.1371/journal.pone.0105897.g009
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Our results therefore support the well-established importance of
IK1 in human atrial electrophysiology [36,54]. Alterations in IK1
may also modulate variations in APD50 and APD20 by modifying
cellular excitability through the resting membrane potential.
Importantly, our study also highlights the importance of
variability in INaK in inter-subject variability in APD90, which
further supports the results of our previous study [34]. Our
findings suggest the need for pharmacological assessment of
potential drug effects on the sodium/potassium pump (as is the
case of amiodarone, for example) due to its importance on atrial
repolarization, in addition to effects on currently evaluated
currents such as sodium, potassium and calcium channels [55–58].
Our population-based results also highlight the importance of
variability in ICaL in determining inter-subject variability in
APD50. However, its role in modulating variability in APD90
and APD20 is less significant. This may explain why some calcium
channel blockers, such as verapamil, significantly reduce the
degree of electrical remodeling, but only yield a minimal reduction
in inducibility of AF, despite aiming to modify tissue refractoriness
in AF patients [59].
Due to its atria specificity and negligible ventricular expression
levels, IKur has been previously proposed as a potentially-
important ionic target for atrial antiarrhythmic therapies aiming
at exclusively prolonging atrial refractoriness [20,42,60–64]. Our
results support its importance in modulating inter-subject
variability in APD50 and APD20, with smaller importance in
modulating APD90. Another important modulator of variability in
APD20 is variability in Ito, which in contrast has only small effects
on APD90 and APD50. This supports the potential of drugs such as
AVE0118, which interfere with both Ito and IKur, and have been
shown to modulate atrial repolarization with no apparent effects
on ventricular repolarization [20,25,61,62]. Further quantitative
studies using the population-based approach could be conducted
to investigate the implications of variability in Gto and GKur in
modulating the response to pharmacological block in SR and cAF.
Finally, our results suggest a secondary role of INaCa in
modulating inter-subject APD variability, as its effects are less
prominent than those of the other currents. However, its influence
on AP morphology cannot be neglected. Recent INaCa inhibitors
have shown the potential to prevent arrhythmogenic events in
ventricular myocardium by decreasing the amplitude of pharma-
cologically-induced early and delayed afterdepolarizations [65,66],
although their effects in atrial tissue still remain unexplored.
The relative importance of certain ionic currents in the
modulation of APD variability displays differences between the
populations based on the three AP models. In particular, the
relevance of INaK in modulating variability in APD90 with the
Courtemanche model population is high but masked by the even
bigger relevance of IK1 and ICaL. Similarly, the relative importance
of IKur in modulating APD20 is masked by those of Ito and ICaL
with the Courtemanche model population, and by IK1 and INaK
with the Grandi model population.
As reviewed in previous papers [6,26–28] and briefly summa-
rized in the Methods section, the three human atrial models
display differences both in equations and parameter values in the
formulations of transmembrane currents and calcium dynamics.
In this study, through the population-based approach, we are able
to assess the relative importance of conductance values versus
model structure in explaining differences in model outputs, and
specifically we are able to identify similarities and differences in the
ability of the populations based on the three AP models to
reproduce experimental APD ranges when conductances are
varied. Our study highlights that, whereas the experimentally-
reported variability in APD90 and APD50 is largely reproduced by
the populations in SR and cAF, the large experimental variability
in APD20 in cAF is difficult to capture and none of model
populations covers its full range, as shown in Figures 2 and 3.
Furthermore, the population based on the Courtemanche model
for instance provides the best agreement in terms of distributions
of APD in SR with respect to those reported experimentally,
whereas the population based on the Maleckar model provides a
better agreement with experimental APD data in cAF, probably
due to its triangular shape. The population based on the Grandi
model in contrast seems better suited for studies related to, for
example, the AP upstroke, since it shows higher variability than
with the Courtemanche and Maleckar models populations, or
mechanisms of arrhythmia due to its ability to reproduce
alternating behavior at fast pacing rates. The differences in the
simulated APs obtained based on the three original models may
arise from differences in the transmembrane current formulation
but also importantly through differences in the calcium dynamics,
as highlighted in previous studies [26,27].
Limitations
The populations of human atrial models developed in the
present study are based on a large amount of experimental
recordings obtained from trabeculae extracted from the right atrial
appendage, which is available from biopsies. Cardiomyocytes from
other atrial locations may exhibit a different degree of variability in
AP [67], which could be investigated using a similar approach to
the one proposed in our study. In this paper, populations of
sampled models account for inter-subject variability in the action
potential of human atrial cells, which in tissue preparations may be
affected by inter-cellular coupling. Effects of tissue coupling could
be investigated in further studies, aiming at translating the
conclusions obtained from cellular to tissue model populations.
Furthermore, experimental data at faster pacing rates than 1 Hz
could help in the populations calibration and the elucidation of the
ionic mechanisms underlying AP variability in rate dependence
[13].
In our study, we examined the effects of variability in a subset of
conductances, which were chosen based on their importance in
determining the atrial AP using a sensitivity analysis [34]. It is
however possible that other electrophysiological properties, such as
ionic concentrations or calcium handling, and additional ionic
currents, such as the background chloride current (IbCL), may play
a role in APD variability. These additional important factors could
be the focus of future investigations.
Conclusions
Our study shows the ability of populations of human atrial cell
models to mimic the remarkable inter-subject variability in human
atrial AP duration and morphology measured in over 450 biopsy
samples obtained from SR and cAF patients. Three different
human atrial cell models are used to construct the populations of
human atrial cell models in SR and cAF, in order to analyse and
evaluate similarities and differences between them. Our simulation
results reveal that relatively modest variations in ionic currents of
630% with respect to their original values yield APD ranges of
250 ms in SR and 190 ms in cAF in the model populations.
The main ionic mechanisms modulating inter-subject variability
in the different phases of the AP are very similar in SR and cAF
populations using the three baseline models. In all cases, ICaL, Ito
and IKur are key in modulating inter-subject differences in APD20
and APD50, whereas IK1 and INaK determine patient-specific
values of APD90. Elucidating likely mechanisms underlying inter-
subject variability in atrial electrophysiological properties may be
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crucial in the understanding of inter-subject differences in human
atrial dynamics and the response to anti-AF pharmacological
therapies. The fact that similar ionic mechanisms are reported
using different models lends credibility to our findings.
Supporting Information
Experimental and simulation data accompanying this publica-
tion are available for download at: http://dx.doi.org/10.6084/
m9.figshare.1031569.
Supporting Information
Figure S1 Experimentally-calibrated human AP model
populations for SR and cAF based on the Maleckar
model. Initial unrestricted 6100% sampled population (A),
experimentally calibrated 630% sampled populations (B) and
histograms corresponding to APD90, APD50 and APD20 distribu-
tions in both the calibrated model populations (C) and the
experimental measurements (D). Histogram bar widths are 10 ms
for both APD90 and APD50, and 4 ms for APD20.
(TIF)
Figure S2 Experimentally-calibrated human AP model
populations for SR and cAF based on the Grandi model.
Initial unrestricted 6100% sampled population (A), experimen-
tally calibrated 630% sampled populations (B) and histograms
corresponding to APD90, APD50 and APD20 distributions in both
the calibrated model populations (C) and the experimental
measurements (D). Histogram bar widths are 10 ms for both
APD90 and APD50, and 4 ms for APD20.
(TIF)
Figure S3 Transmembrane potential and ionic current
traces in SR and cAF for the populations based on the
Courtemanche model. Traces in SR (left) and cAF (right) for
models displaying maximum APD90 (red dash-dotted lines),
minimum APD90 (black dash-dotted lines), maximum APD50
(red thin solid lines), minimum APD50 (black thin solid lines),
maximum APD20 (red dashed lines) and minimum APD20 (black
dashed lines).
(TIF)
Figure S4 Transmembrane potential and ionic current
traces in SR and cAF for the populations based on the
Grandi model. Traces in SR (left) and cAF (right) for models
displaying maximum APD90 (red dash-dotted lines), minimum
APD90 (black dash-dotted lines), maximum APD50 (red thin solid
lines), minimum APD50 (black thin solid lines), maximum APD20
(red dashed lines) and minimum APD20 (black dashed lines).
(TIF)
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